Scott DL, Wolfe F, Huizinga TW: Rheumatoid arthritis. Lancet. 2010, 376: 1094-1108. 10.1016/S0140-6736(10)60826-4.
Article
PubMed
Google Scholar
Gibbons LJ, Hyrich KL: Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response. BioDrugs. 2009, 23: 111-124. 10.2165/00063030-200923020-00004.
Article
CAS
PubMed
Google Scholar
Mima T, Nishimoto N: Clinical value of blocking IL-6 receptor. Curr Opin Rheumatol. 2009, 21: 224-230. 10.1097/BOR.0b013e3283295fec.
Article
CAS
PubMed
Google Scholar
Buch MH, Emery P: New therapies in the management of rheumatoid arthritis. Curr Opin Rheumatol. 2011, 23: 245-251. 10.1097/BOR.0b013e3283454124.
Article
CAS
PubMed
Google Scholar
Bergman MJ: Assessing adequate treatment response in patients with rheumatoid arthritis. Clin Ther. 2009, 31: 1219-1231. 10.1016/j.clinthera.2009.06.005.
Article
CAS
PubMed
Google Scholar
Auffray C, Sieweke MH, Geissmann F: Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009, 27: 669-92. 10.1146/annurev.immunol.021908.132557.
Article
CAS
PubMed
Google Scholar
Komano Y, Nanki T, Hayashida K, Taniguchi K, Miyasaka N: Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther. 2006, 8: R152-10.1186/ar2046.
Article
PubMed Central
PubMed
Google Scholar
Grage-Griebenow E, Flad HD, Ernst M: Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol. 2001, 69: 11-20.
CAS
PubMed
Google Scholar
Gordon S, Taylor PR: Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005, 5: 953-964. 10.1038/nri1733.
Article
CAS
PubMed
Google Scholar
Geissmann F, Jung S, Littman DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003, 19: 71-82. 10.1016/S1074-7613(03)00174-2.
Article
CAS
PubMed
Google Scholar
Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB: Nomenclature of monocytes and dendritic cells in blood. Blood. 2010, 21: e74-80.
Article
Google Scholar
Szekanecz Z, Koch AE: Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol. 2007, 19: 289-295. 10.1097/BOR.0b013e32805e87ae.
Article
PubMed
Google Scholar
Robbins CS, Swirski FK: The multiple roles of monocyte subsets in steady state and inflammation. Cell Mol Life Sci. 2010, 67: 2685-2693. 10.1007/s00018-010-0375-x.
Article
CAS
PubMed
Google Scholar
Hochberg MC, Tracy JK, Hawkins-Holt M, Flores RH: Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis. Ann Rheum Dis. 2003, 62 (Suppl. 2): ii13-ii16.
PubMed Central
CAS
PubMed
Google Scholar
Kristensen LE, Christensen R, Bliddal H, Geborek P, Danneskiold-Samsoe B, Saxne T: The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review. Scand J Rheumatol. 2007, 36: 411-417. 10.1080/03009740701607067.
Article
CAS
PubMed
Google Scholar
Mewar D, Wilson AG: Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors. Br J Pharmacol. 2011, 162: 785-791. 10.1111/j.1476-5381.2010.01099.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bartelds GM, Wijbrandts CA, Nurmohamed MT, Stapel S, Lems WF, Aarden L, Dijkmans BA, Tak PP, Wolbink GJ: Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 921-926. 10.1136/ard.2006.065615.
Article
PubMed Central
CAS
PubMed
Google Scholar
van Gestel AM, Prevoo ML, van 't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996, 34-40. 39
González VM, Stewart A, Ritter PL, Lorig K: Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum. 1995, 38: 1429-1446. 10.1002/art.1780381010.
Article
PubMed
Google Scholar
Böyum AJ: Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest. 1968, 21: 77-89. 10.3109/00365516809076979.
Article
Google Scholar
Burmester GR, Mariette X, Montecucco C, Monteagudo-Sáez I, Malaise M, Tzioufas AG, Bijlsma JW, Unnebrink K, Kary S, Kupper H: Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Ann Rheum Dis. 2007, 66: 732-739. 10.1136/ard.2006.066761.
Article
PubMed Central
CAS
PubMed
Google Scholar
Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, Kekow J, Thiesen HJ: Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept. Arthritis Res Ther. 2008, 10: R50-10.1186/ar2419.
Article
PubMed Central
PubMed
Google Scholar
Stuhlmüller B, Häupl T, Hernandez MM, Grützkau A, Kuban RJ, Tandon N, Voss JW, Salfeld J, Kinne RW, Burmester GR: CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis. Clin Pharmacol Ther. 2010, 87: 311-321. 10.1038/clpt.2009.244.
Article
PubMed
Google Scholar
Klaasen R, Thurlings RM, Wijbrandts CA, van Kuijk AW, Baeten D, Gerlag DM, Tak PP: The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study. Arthritis Rheum. 2009, 60: 3217-3224. 10.1002/art.24913.
Article
CAS
PubMed
Google Scholar
Hueber W, Tomooka BH, Batliwalla F, Li W, Monach PA, Tibshirani RJ, Van Vollenhoven RF, Lampa J, Saito K, Tanaka Y, Genovese MC, Klareskog L, Gregersen PK, Robinson WH: Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Res Ther. 2009, 11: R76-10.1186/ar2706.
Article
PubMed Central
PubMed
Google Scholar
Fabre S, Dupuy AM, Dossat N, Guisset C, Cohen JD, Cristol JP, Daures JP, Jorgensen C: Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis. Clin Exp Immunol. 2008, 153: 188-195. 10.1111/j.1365-2249.2008.03691.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Barrera P, Blom A, van Lent PL, van Bloois L, Beijnen JH, van Rooijen N, de Waal Malefijt MC, van de Putte LB, Storm G, van den Berg WB: Synovial macrophage depletion with clodronatecontaining liposomes in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 1951-1959. 10.1002/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K.
Article
CAS
PubMed
Google Scholar
Kashiwagi N, Nakano M, Saniabadi AR, Adachi M, Yoshikawa T: Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis. Inflammation. 2002, 26: 199-205. 10.1023/A:1016523914161.
Article
PubMed
Google Scholar
Buchan GS, Palmer DG, Gibbins BL: The response of human peripheral blood mononuclear phagocytes to rheumatoid arthritis. J Leukoc Biol. 1985, 37: 221-230.
CAS
PubMed
Google Scholar
Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP: Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008, 117: 244-279. 10.1016/j.pharmthera.2007.10.001.
Article
CAS
PubMed
Google Scholar
Bresnihan B, Gerlag DM, Rooney T, Smeets TJ, Wijbrandts CA, Boyle D, Fitzgerald O, Kirkham BW, McInnes IB, Smith M, Ulfgren AK, Veale DJ, Tak PP: Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers. J Rheumatol. 2007, 34: 620-622.
PubMed
Google Scholar
Taylor PC, Peters AM, Paleolog E, Chapman PT, Elliott MJ, McCloskey R, Feldmann M, Maini RN: Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor a blockade in patients with rheumatoid arthritis. Arthritis Rheum. 2000, 43: 38-47. 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L.
Article
CAS
PubMed
Google Scholar
McInnes IB, Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007, 7: 429-442. 10.1038/nri2094.
Article
CAS
PubMed
Google Scholar
Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK: Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum. 2005, 52: 61-72. 10.1002/art.20764.
Article
CAS
PubMed
Google Scholar
Shen C, Maerten P, Geboes K, Van Assche G, Rutgeerts P, Ceuppens JL: Infliximab induces apoptosis of monocytes and T lymphocytes in a human-mouse chimeric model. Clin Immunol. 2005, 115: 250-259. 10.1016/j.clim.2005.01.007.
Article
CAS
PubMed
Google Scholar
Meugnier E, Coury F, Tebib J, Ferraro-Peyret C, Rome S, Bienvenu J, Vidal H, Sibilia J, Fabien N: Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments. Physiol Genomics. 2011, 43: 365-371. 10.1152/physiolgenomics.00127.2010.
Article
CAS
PubMed
Google Scholar
Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BA, Tak PP: The clinical response to infliximab in rheumatoid arthritis is in part dependent on pre-treatment TNFa expression in the synovium. Ann Rheum Dis. 2008, 67: 1139-1144. 10.1136/ard.2007.080440.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hamilton JA, Tak PP: The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum. 2009, 60: 1210-1221. 10.1002/art.24505.
Article
PubMed
Google Scholar
Lindberg J, Wijbrandts CA, van Baarsen LG, Nader G, Klareskog L, Catrina A, Thurlings R, Vervoordeldonk M, Lundeberg J, Tak PP: The gene expression profile in the synovium as a predictor of the clinical response to infliximab treatment in rheumatoid arthritis. PLoS One. 2010, 5: e11310-10.1371/journal.pone.0011310.
Article
PubMed Central
PubMed
Google Scholar